Accessibility Menu
 
Harrow logo

Harrow

(NASDAQ) HROW

Current Price$31.09
Market Cap$1.16B
Since IPO (2007)+261%
5 Year+248%
1 Year+22%
1 Month-20%

Harrow Financials at a Glance

Market Cap

$1.16B

Revenue (TTM)

$268.68M

Net Income (TTM)

$14.96M

EPS (TTM)

$-0.41

P/E Ratio

-76.38

Dividend

$0.00

Beta (Volatility)

1.03 (Average)

Price

$31.09

Volume

432,039.947

Open

$31.07

Previous Close

$31.21

Daily Range

$30.56 - $31.68

52-Week Range

$25.21 - $54.85

HROW: Motley Fool Moneyball Superscore

67

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Harrow

Industry

Pharmaceuticals

Employees

373

CEO

Mark L. Baum

Headquarters

Nashville, TN 37205, US

HROW Financials

Key Financial Metrics (TTM)

Gross Margin

74%

Operating Margin

10%

Net Income Margin

-6%

Return on Equity

-35%

Return on Capital

9%

Return on Assets

-4%

Earnings Yield

-1.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.16B

Shares Outstanding

37.28M

Volume

432.04K

Avg. Volume

836.40K

Financials (TTM)

Gross Profit

$204.37M

Operating Income

$38.61M

EBITDA

$57.52M

Operating Cash Flow

$43.86M

Capital Expenditure

$887.00K

Free Cash Flow

$42.98M

Cash & ST Invst.

$72.93M

Total Debt

$251.98M

Harrow Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$44.20M

-7.6%

Gross Profit

$27.05M

-16.3%

Gross Margin

61.18%

N/A

Market Cap

$1.16B

N/A

Market Cap/Employee

$3.05M

N/A

Employees

382

N/A

Net Income

$27.60M

-55.2%

EBITDA

$16.50M

-146.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$206.02M

-26.2%

Accounts Receivable

$101.26M

+31.0%

Inventory

$16.50M

+53.9%

Long Term Debt

$299.75M

+147.6%

Short Term Debt

$915.00K

-99.2%

Return on Assets

-3.57%

N/A

Return on Invested Capital

8.57%

N/A

Free Cash Flow

$9.19M

-147.2%

Operating Cash Flow

$8.99M

-145.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KMTSKestra Medical Technologies, Ltd.
$19.56-1.31%
COLLCollegium Pharmaceutical, Inc.
$34.05+0.80%
BLFSBioLife Solutions, Inc.
$22.00+5.97%
ALVOAlvotech
$3.25-1.81%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.99-0.07%
TQQQProShares Trust - ProShares UltraPro Qqq
$72.39-0.04%
ONDSOndas
$9.61-0.10%
POETPoet Technologies
$13.81-0.14%

Questions About HROW

What is the current price of Harrow?

Harrow is trading at $31.05 per share.

What is the 52-week range for Harrow?

Over the past 52 weeks, Harrow has traded between $25.21 and $54.85.

How much debt does Harrow have?

As of the most recent reporting period, Harrow reported total debt of $300.67M.

How much cash does Harrow have on hand?

Harrow reported $94.64M in cash and cash equivalents in its most recent financial results.

What is Harrow’s dividend yield?

Harrow does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.